EUR/USD
1.16364
0.029%
Gold
4399.96
-0.036%
Oil
94.345
0.141%
USD/JPY
153.352
-0.128%
GBP/USD
1.35506
0.034%
GBP/JPY
207.807
-0.075%
Real-time News
On September 10th, according to The Information, OpenAI has informed some business partners that it will no longer accept advertising for image and audio generation products, as these products compete with OpenAIs own functionality. This change was not previously reported and was not included in its published advertising policy, catching existing advertisers like Adobe, which sells such products, off guard. If this new policy extends to other competing products, it could limit OpenAIs potential advertising revenue. OpenAI had previously given investors aggressive advertising growth expectations, viewing advertising as a key way to generate revenue from its large non-paying user base.On September 10th, Mehmet Oz, head of the Centers for Medicare & Medicaid Services (CMS), stated that the Trump administration is seeking more drug pricing agreements with pharmaceutical companies. To date, officials have announced more than twenty "voluntary" agreements with pharmaceutical companies, and Oz indicated that "more agreements are in the works." These agreements vary, but companies typically agree to lower the prices they charge public healthcare programs and launch new drugs at prices comparable to those in other developed countries in exchange for tariff reductions.A Reuters poll found that 74% of economists believe Japan’s total budget request for fiscal year 2027 has exacerbated market concerns about fiscal discipline.A Reuters poll showed that 62% of economists expect the Bank of Japan to raise interest rates to at least 1.75% in the second quarter of 2027 (previously the survey expected a final rate of 1.50%).A Reuters poll shows that 97% of economists expect the Bank of Japan to raise interest rates to 1.25% on September 18 (compared to 57% in the August survey).
